238 Civitan Bldg, Durham, NC 27710
Box 3173 Med Ctr, Durham, NC 27710
My major research interest is in examining the effectiveness of services for severely mentally ill individuals, including factors that improve or impede good outcomes. Current research includes: the effectiveness of involuntary outpatient commitment, psychiatric advance directives, criminal justice outcomes for persons with mental illnesses, violence and mental illness and antipsychotic medications.
I also served as member of the MacArthur Foundation Research Network on Mandated Community Treatment. In this and related work we are examining the role legal tools such as Psychiatric Advance Directives may play in improving outcomes for persons with severe mental illness. In this regard, I served as Co-PI with Jeffrey Swanson of a NIMH study examining the effectiveness of Psychiatric Advance Directives and a MacArthur Foundation grant supporting their dissemination. We are also evaluating New York's Assisted Outpatient Treatment Program (Kendra's Law) and estimating the cost of criminal justice involvement in severely mentally ill individuals.
I am also involved in clinical trials in schizophrenia and served as Co-PI of the NIMH funded Clinical Antipsychotics Trials of Intervention Effectiveness study investigating the role of antipsychotics in treatment outcomes in schizophrenia and Alzheimer’s Disease.
Gender-specific participation and outcomes among jail diversion clients with co-occurring substance use and mental health disorders.
Mental Health Policy in the Era of COVID-19.
A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
Thinking Carefully About Marijuana Legalization: Public Health Considerations for State Policy Makers.
Criminal Justice and Suicide Outcomes with Indiana's Risk-Based Gun Seizure Law.
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.
Update on Assisted Outpatient Treatment.
Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.
Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes.
Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.
Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment.
Randomised controlled trials and outpatient commitment.
Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
Facilitation of Psychiatric Advance Directives by Peers and Clinicians on Assertive Community Treatment Teams.
Leading indicators of community-based violent events among adults with mental illness.
Alternatives to the Emergency Department: In Reply.
Involuntary Outpatient Commitment and the Elusive Pursuit of Violence Prevention.
Victimization of persons with severe mental illness: a pressing global health problem.
Implementation and effectiveness of connecticut's risk-based gun removal law: Does it prevent suicides?Read Full Text
A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses.
Treatment utilization among persons with opioid use disorder in the United States.
The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.
Emergency Department Boarding: Nowhere Else to Go.
A Randomized Clinical Trial of a Money Management Intervention for Veterans With Psychiatric Disabilities.
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
Trends in cannabis use disorders among racial/ethnic population groups in the United States.
Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses.
Gun Violence, Mental Illness, And Laws That Prohibit Gun Possession: Evidence From Two Florida Counties.
Increasing Access to State Psychiatric Hospital Beds: Exploring Supply-Side Solutions.
Mental Health Courts: Does Treatment Make a Difference?
Consideration of all evidence about community treatment orders.
Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness.
Readmission Patterns and Effectiveness of Transitional Care Among Medicaid Patients With Schizophrenia and Medical Comorbidity.
Emergency Psychiatry Experience, Resident Burnout, and Future Plans to Treat Publicly Funded Patients.
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Guns, Impulsive Angry Behavior, and Mental Disorders: Results from the National Comorbidity Survey Replication (NCS-R).
The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission.
Perceived cannabis use norms and cannabis use among adolescents in the United States.
Latent class analysis of discordance between results of drug use assessments in the CATIE data.
Community violence perpetration and victimization among adults with mental illnesses.
Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States.
Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness.
Mental health and reoffending outcomes of jail diversion participants with a brief incarceration after arraignment.
How do mental health courts work?
Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors.
Why the evidence for outpatient commitment is good enough.
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.
Response to Burns.
Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.
The cost of assisted outpatient treatment: can it save states money?
Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.
The prevalence and distribution of major depression in a national community sample: The national comorbidity surveyRead Full Text
Tobacco use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals: 2002-2010.
Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.
Adverse impact of coercive treatments on psychiatric inpatients' satisfaction with care.
Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study.
Costs of criminal justice involvement among persons with serious mental illness in connecticut.
Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.
Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.
Preventing gun violence involving people with serious mental illnessRead Full Text
Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults.
A recovery-oriented money management intervention.
Economic grand rounds: Can states implement involuntary outpatient commitment within existing state budgets?
Assessing illicit drug use among adults with schizophrenia.
In-home mental health treatment for individuals with HIV.
Alcohol and drug use disorders among adults in emergency department settings in the United States.
Public behavioral health care reform in North Carolina: will we get it right this time around?
LONGITUDINAL SUBSTANCE USE TRAJECTORIES FOR PERSONS WITH SCHIZOPHRENIARead Full Text
Psychiatric violence risk assessmentRead Full Text
Criminal justice system involvement among people with schizophrenia.
Substance use and schizophrenia: adverse correlates in the CATIE study sample.
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.
Storm clouds over the public mental health safety net.
The association between weight change and symptom reduction in the CATIE schizophrenia trial.
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
The impact of evidence-based education on prescribing in a psychiatry residency.
A conceptually based scale to measure consumers' treatment motivationRead Full Text
Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.
Reductions in arrest under assisted outpatient treatment in New York.
Assisted outpatient treatment in New York: regional differences in New York's assisted outpatient treatment program.
Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York.
Robbing Peter to pay Paul: did New York State's outpatient commitment program crowd out voluntary service recipients?
Introduction to the special section on assisted outpatient treatment in New York State.
Changes in guideline-recommended medication possession after implementing Kendra's law in New York.
Assessing outcomes for consumers in New York's assisted outpatient treatment program.
Advancing research at the intersection of two systems.
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
Psychiatric advance directives and social workers: an integrative review.
Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial.
Psychosocial functioning in patients with chronic schizophrenia: Findings from the NIMH CATIE studyRead Full Text
Substance use in persons with schizophrenia: Incidence, baseline correlates, and effects on outcomeRead Full Text
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
Preferences for psychiatric advance directives among Latinos: views on advance care planning for mental health.
Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial.
Autonomy and the use of directive intervention in the treatment of individuals with serious mental illnesses: A survey of social work practitionersRead Full Text
Taking issueRead Full Text
Racial disparities in involuntary outpatient commitment: are they real?
Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
Results of phase 3 of the CATIE schizophrenia trial.
The impact of obesity on health care costs among persons with schizophrenia.
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial.
Reducing barriers to completing psychiatric advance directives.
Extrapyramidal side-effects of antipsychotics in a randomised trial.
Performance measures for mental healthcare in Singapore.
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
Relationship of cognition and psychopathology to functional impairment in schizophrenia.
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.
A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness.
Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behavior problems.
Introduction to the CATIE special section.
Who are the new users of antipsychotic medications?
What CATIE found: results from the schizophrenia trial.
Social workers' familiarity with psychiatric advance directives: Implications for education, practice, and researchRead Full Text
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
Caregivers as money managers for adults with severe mental illness: how treatment providers can help.
Assessing risk of violent behavior among veterans with severe mental illness.
Front line workers' attitudes towards psychiatric advance directives.
Psychiatric advance directives and reduction of coercive crisis interventions.
Comparison of Antipsychotics for Metabolic Problems (CAMP): A NIMH schizophrenia trials network studyRead Full Text
An integrated, multidimensional treatment model for individuals living with HIV, mental illness, and substance abuse.
Relation of lifetime trauma and depressive symptoms to mortality in HIV.
Characteristics of representative payeeship involving families of beneficiaries with psychiatric disabilities.
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.
EFFECTIVELY IMPLEMENTING PSYCHIATRIC ADVANCE DIRECTIVES TO PROMOTE SELF-DETERMINATION OF TREATMENT AMONG PEOPLE WITH MENTAL ILLNESS.
Authors' reply Read Full Text
Childhood abuse and initial presentation for HIV care: an opportunity for early intervention.
Effect of patients' reasons for refusing treatment on implementing psychiatric advance directives.
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.
Commentary: psychiatric advance directives and recovery-oriented care.
Effectiveness of atypical antipsychotics for substance use in schizophrenia patients.
Healthcare barriers among severely mentally ill homeless adults: evidence from the five-site health and risk study.
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Can mandated outpatient treatment prevent tragedies?
Competence to complete psychiatric advance directives: effects of facilitated decision making.
Re: Community treatment orders for psychiatric patients: the emperor with no clothes.
Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial.
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study.
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
The impact of perceived need for treatment on risk of arrest and violence among people with severe mental illnessRead Full Text
Overriding psychiatric advance directives: factors associated with psychiatrists' decisions to preempt patients' advance refusal of hospitalization and medication.
Dr. Rosenheck and colleagues reply Read Full Text
Dr. Swanson and colleagues reply Read Full Text
Understanding the personal and clinical utility of psychiatric advance directives: a qualitative perspective.
Psychiatric advance directives: a tool for consumer empowerment and recovery.
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trialRead Full Text
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
The relationship between mandated community treatment and perceived barriers to care in persons with severe mental illness.
Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.
Treatment engagement and violence risk in mental disorders.
Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia.
Components and correlates of family burden in schizophrenia.
Introduction to the special section on CATIE baseline data: practical clinical trials in psychiatry: studies of schizophrenia from the CATIE network.
Violence and leveraged community treatment for persons with mental disorders.
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.
Clinicians' attitudes regarding barriers to the implementation of psychiatric advance directives.
Prevalence of childhood sexual abuse and physical trauma in an HIV-positive sample from the deep south.
Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events.
Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder.
A national study of violent behavior in persons with schizophrenia.
Interrelationships of psychiatric symptom severity, medical comorbidity and functional status in patients with schizophreniaRead Full Text
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Exploring lack of trust in care providers and the government as a barrier to health service use.
Dr. Lieberman and Colleagues reply Read Full Text
Clinical decision making and views about psychiatric advance directives.
Use of outpatient commitment or related civil court treatment orders in five U.S. communities.
Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Barriers to employment for people with schizophrenia.
Dr. Lieberman and Colleagues ReplyRead Full Text
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
Patient preferences for psychiatric advance directivesRead Full Text
Mental illness in U.S. Presidents between 1776 and 1974: a review of biographical sources.
S.14.04 CATIE trial resultsRead Full Text
Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates.
Superseding psychiatric advance directives: ethical and legal considerations.
"Conscience clauses" or "unconscionable clauses": personal beliefs versus professional responsibilities.
Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
Measuring outcome priorities and preferences in people with schizophrenia.
The effects of early sexual abuse on adult risky sexual behaviors among persons with severe mental illness.
Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
Family representative payeeship and violence risk in severe mental illness.
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Cost-sharing requirements and access to mental health care among medicare enrollees with schizophrenia.
The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south.
Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) projectRead Full Text
A brief mental health and substance abuse screener for persons with HIV.
Perceived fairness and effectiveness of leveraged community treatment among public mental health consumers in five U.S. citiesRead Full Text
Psychiatrists’ views and attitudes about psychiatric advance directivesRead Full Text
Previous involuntary commitment is associated with current perceptions of coercion in voluntarily hospitalized patientsRead Full Text
Use of leverage to improve adherence to psychiatric treatment in the community.
Consumer views of representative payee use of disability funds to leverage treatment adherence.
Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.
A comparison of stigmatizing attitudes toward persons with schizophrenia in four stakeholder groups: perceived likelihood of violence and desire for social distance.
Psychiatric advance directives: Practical, legal, and ethical issuesRead Full Text
Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone.
Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data?
Caregiving for persons with mental illness: the impact of outpatient commitment on caregiving strain.
Consumers' perceptions of the fairness and effectiveness of mandated community treatment and related pressures.
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness.
Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates.
Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment.
Effects of legal mechanisms on perceived coercion and treatment adherence among persons with severe mental illness.
Mental health care in North Carolina: challenges on the road to reform.
Mandated treatment in the community for people with mental disorders.
Characteristics of third-party money management for persons with psychiatric disabilities.
Substance abuse and the transmission of hepatitis C among persons with severe mental illness.
Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness.
The five-site health and risk study of blood-borne infections among persons with severe mental illness.
Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair.
Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection.
Assessment of four stakeholder groups' preferences concerning outpatient commitment for persons with schizophrenia.
Endorsement of personal benefit of outpatient commitment among persons with severe mental illness.
Involuntary outpatient commitment and homelessness in persons with severe mental illness.
Does involuntary outpatient commitment lead to more intensive treatment?
Psychiatric disability, the use of financial leverage, and perceived coercion in mental health servicesRead Full Text
Psychiatric advance directives: A survey of persons with schizophrenia, family members, and treatment providersRead Full Text
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
Does fear of coercion keep people away from mental health treatment? Evidence from a survey of persons with schizophrenia and mental health professionals.
Effects of involuntary outpatient commitment on subjective quality of life in persons with severe mental illness.
The social-environmental context of violent behavior in persons treated for severe mental illness.
Erratum: Victimization: A link between mental illness and violence? (International Journal of Law and Psychiatry (2001) 24 (559-572) PII: S0160252701000917)Read Full Text
Impact of outpatient commitment on victimization of people with severe mental illness.
The impact of borderline personality disorder on post-traumatic stress in the community: a study of health status, health utilization, and functioning.
The Impact of Borderline Personality Disorder on Post-Traumatic Stress in the Community: A Study of Health Status, Health Utilization, and FunctioningRead Full Text
Coercion in mental Health careRead Full Text
The perceived coerciveness of involuntary outpatient commitment: findings from an experimental study.
Concealed medicines for people with schizophrenia: a U.S. perspective.
Victimization: a link between mental illness and violence?
Assessing the New York City involuntary outpatient treatment program.
Recent victimization in women and men with severe mental illness: prevalence and correlates.
Mandated community treatment: beyond outpatient commitment.
Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness.
Confusion about outpatient commitment.
Effectiveness of involuntary outpatient commitment.
Special section on involuntary outpatient commitment: introduction.
A randomized controlled trial of outpatient commitment in North Carolina.
Assessing the New York City involuntary outpatient commitment pilot program.
Can involuntary outpatient commitment reduce arrests among persons with severe mental illness?Read Full Text
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.
Race, role responsibility, and relationship: understanding the experience of caring for the severely mentally illRead Full Text
Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness.
Psychiatric advance directives: an alternative to coercive treatment?
Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals.
Consumer perceptions of involuntary outpatient commitment.
Functional impairment and utilization of services associated with posttraumatic stress in the community.
Violent behavior preceding hospitalization among persons with severe mental illness.
Criminal victimization of persons with severe mental illness.
Measuring coercion under involuntary outpatient commitment: Initial findings from a randomized controlled trial.Read Full Text
Psychiatric impairment, social contact, and violent behavior: evidence from a study of outpatient-committed persons with severe mental disorder.
Risk reconsidered: targets of violence in the social networks of people with serious psychiatric disorders.
Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals.
Male-female differences in the setting and construction of violence among people with severe mental illness.
Treatment boundaries in the case management relationship: a clinical case and discussion.
Administrative update: utilization of services. I. Comparing use of public and private mental health services: the enduring barriers of race and age.
Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.
Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey.
Substance abuse, violent behavior, and police encounters among persons with severe mental disorderRead Full Text
The ethical challenges of a randomized controlled trial of involuntary outpatient commitmentRead Full Text
Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey.
The US National Comorbidity Survey: overview and future directions.
Violence and severe mental disorder in clinical and community populations: the effects of psychotic symptoms, comorbidity, and lack of treatment.
Interpreting the effectiveness of involuntary outpatient commitment: a conceptual model.
Patient perceptions of coercion in mental hospital admission.
The ethical challenges of a randomized controlled trial of involuntary outpatient commitment.
Psychotic symptoms and disorders and the risk of violent behaviour in the communityRead Full Text
Assessing and managing voilence risk in clinical practiceRead Full Text
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.Read Full Text
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.
Psychotic symptoms and disorders and the risk of violent behaviour in the communityRead Full Text
New directions in research on involuntary outpatient commitment.
The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services.
State purchasing cooperatives for psychotropic medication.
The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey.
Adult onset of severe and pervasive antisocial behavior: A distinct syndrome?Read Full Text
Sex and depression in the National Comorbidity Survey. II: Cohort effects.
Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.
Deciding to terminate treatment: a practical guide for physicians.
Long-term psychosocial effects of childhood exposure to parental problem drinking.
Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.
Somatization DisorderRead Full Text
Generalized Anxiety DisorderRead Full Text
Social outcomes related to age of onset among psychiatric disorders.
Is there a place for lawyers on ethics committees? A view from the inside.
Sexual assault and psychiatric disorders among a community sample of women.
Estimating the prevalence of borderline personality disorder in the communityRead Full Text
P.T. Barnum and the borderline personality disorder muddle (I: Reply)Read Full Text
Concept of interpersonal distance in borderline personality disorder (Reply)Read Full Text
Oscillations of attachment in borderline personality disorder.
Antisocial and related disorders in a southern community. An application of grade of membership analysis.
Identification of borderline personality disorder with the NIMH Diagnostic Interview Schedule.
Antisocial and related disorders in a southern community: An application of grade of membership analysisRead Full Text
In response to 'psychiatric diagnosis as reified measurement'. An invited comment on Mirowsky and Ross (1989)Read Full Text
Somatization symptoms in the community: a rural/urban comparison.
Medically unexplained physical symptoms, somatization disorder and abridged somatization: studies with the Diagnostic Interview Schedule.
Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification.
Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims.
The Inpatient Milieu: Organizational and Functional PrinciplesRead Full Text
AIDS testing and informed consent.
Somatization disorder in the community. A study of diagnostic concordance among three diagnostic systems.
What constitutes a psychiatric emergency: clinical and legal dimensions.
A study of somatization disorder in a community population utilizing grade of membership analysis.
Somatization disorder in a community population.
Somatization disorder in a US southern community: use of a new procedure for analysis of medical classification.
Emergency room management of conversion disorders.
Developing a screening index for community studies of somatization disorder.
Special clinical problems in the management of psychiatric inpatients.
Stelazine advertisement "dismays" readers.
A diagnostic and family study of posttraumatic stress disorder.
Diagnosis and disposition.
Funeral mania in recurrent bipolar affective disorders: reports of three cases.
Countertransference in the expectant father.
Funeral mania in recurrent bipolar affective disorders: Reports of three casesRead Full Text
A case of intermittent delirious mania.
Can involuntary outpatient commitment reduce hospital recidivism?: findings from a randomized trial with severely mentally ill individualsRead Full Text
Involuntary outpatient commitment and reduction of violent behavior in persons with severe mental illnessRead Full Text